venBio Global Strategic Fund III, L.P.

Overview

• HeadquartersE9¹

See how the biggest companies compare on our leaderboards

Corporate structure

venBio Global Strategic Fund III, L.P. sits at the top of its group. 7 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (6 companies). Each entity in the chart links to its source.

Stakes it holds

venBio Global Strategic Fund III, L.P. has told the SEC it owns more than 5% of 6 companies, latest first (Schedules 13D and 13G).

• Artiva Biotherapeutics, Inc.SCHEDULE 13G/A Aug 1, 2024 to May 15, 2025²
• Elevation Oncology, Inc.SC 13D/A May 27, 2022 to Aug 8, 2024³
• RayzeBio, Inc.SC 13G Feb 9, 2024⁴
• Pharvaris N.V.SC 13D/A Sep 26, 2022 to Jan 25, 2024⁵
• Ventyx Biosciences, Inc.SC 13D/A Nov 4, 2021 to Jan 30, 2023⁶
• CinCor Pharma, Inc.SC 13G/A Jan 11, 2022 to Sep 26, 2022⁷